Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19

Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19

Abstract A high proportion of patients with coronavirus disease 2019 (COVID-19) experience post-acute COVID-19, including neuropsychiatric symptoms. Objective signs of central nervous system (CNS) damage can be investigated using CNS biomarkers such as glial fibrillary acidic protein (GFAp), neurofi...

Full description

Bibliographic Details
Main Authors:	Lovisa Bark, Ing-Marie Larsson, Ewa Wallin, Joel Simrén, Henrik Zetterberg, Miklos Lipcsey, Robert Frithiof, Elham Rostami, Michael Hultström
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-08-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-39698-y

Similar Items

Severe acute kidney injury associated with progression of chronic kidney disease after critical COVID-19
by: Michael Hultström, et al.
Published: (2021-01-01)

Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia
by: Assunta Ingannato, et al.
Published: (2024-04-01)

Emergence delirium and postoperative delirium associated with high plasma NfL and GFAP: an observational study
by: Xingyang Liu, et al.
Published: (2023-07-01)

Sex Differences in Behavioral Symptoms and the Levels of Circulating GFAP, Tau, and NfL in Patients With Traumatic Brain Injury
by: Dilorom Sass, et al.
Published: (2021-11-01)

Neurochemical Monitoring of Traumatic Brain Injury by the Combined Analysis of Plasma Beta-Synuclein, NfL, and GFAP in Polytraumatized Patients
by: Rebecca Halbgebauer, et al.
Published: (2022-08-01)

A comparison of impact of comorbidities and demographics on 60-day mortality in ICU patients with COVID-19, sepsis and acute respiratory distress syndrome
by: Björn Ahlström, et al.
Published: (2022-09-01)

Plasma Leptin Is Increased in Intensive Care Patients with COVID-19—An Investigation Performed in the PronMed-Cohort
by: Anders Larsson, et al.
Published: (2021-12-01)

Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias
by: Simone Baiardi, et al.
Published: (2022-10-01)

Shrunken Pore Syndrome Is Frequently Occurring in Severe COVID-19
by: Anders O. Larsson, et al.
Published: (2022-12-01)

Surviving COVID-19: patients’ experiences of care and path to recovery
by: Rakel Eklund, et al.
Published: (2024-12-01)

Health-related quality of life after surviving intensive care for COVID-19: a prospective multicenter cohort study
by: Peter Halvorsen, et al.
Published: (2023-10-01)

Plasma UCHL1, GFAP, Tau, and NfL Are Not Different in Young Healthy Persons With Mild COVID-19 Symptoms Early in the Pandemic: A Pilot Study
by: Matthew J. Rogatzki, et al.
Published: (2023-05-01)

Serum assessment of traumatic axonal injury: the correlation of GFAP, t-Tau, UCHL-1 and NfL levels with Diffusion Tensor Imaging metrics and its prognosis utility.
by: A.M. Castaño-Leon, et al.
Published: (2022-01-01)

Prior physical illness predicts death better than acute physiological derangement on intensive care unit admission in COVID-19: A Swedish registry study.
by: Karl Stattin, et al.
Published: (2023-01-01)

Prior physical illness predicts death better than acute physiological derangement on intensive care unit admission in COVID-19: A Swedish registry study
by: Karl Stattin, et al.
Published: (2023-01-01)

Differential Bias for Creatinine- and Cystatin C- Derived Estimated Glomerular Filtration Rate in Critical COVID-19
by: Anders O. Larsson, et al.
Published: (2022-10-01)

Serum GFAP, NfL, and tau concentrations are associated with worse neurobehavioral functioning following mild, moderate, and severe TBI: a cross-sectional multiple-cohort study
by: Katie A. Edwards, et al.
Published: (2024-01-01)

Correction: Berghäll et al. The Evolution of Blood Cell Phenotypes, Intracellular and Plasma Cytokines and Morphological Changes in Critically Ill COVID-19 Patients. <i>Biomedicines</i> 2022, <i>10</i>, 934
by: Elisabeth Berghäll, et al.
Published: (2023-11-01)

The Evolution of Blood Cell Phenotypes, Intracellular and Plasma Cytokines and Morphological Changes in Critically Ill COVID-19 Patients
by: Elisabeth Berghäll, et al.
Published: (2022-04-01)

Blood type A associates with critical COVID-19 and death in a Swedish cohort
by: Michael Hultström, et al.
Published: (2020-08-01)

Weak anti-SARS-CoV-2 antibody response is associated with mortality in a Swedish cohort of COVID-19 patients in critical care
by: Sana Asif, et al.
Published: (2020-11-01)

Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
by: Priscilla Youssef, et al.
Published: (2023-03-01)

Immuno-Modulatory Effects of Dexamethasone in Severe COVID-19—A Swedish Cohort Study
by: Sana Asif, et al.
Published: (2023-01-01)

Performance of biomarkers NF-L, NSE, Tau and GFAP in blood and cerebrospinal fluid in rat for the detection of nervous system injury
by: Katerina Vlasakova, et al.
Published: (2024-01-01)

Chest dual-energy CT to assess the effects of steroids on lung function in severe COVID-19 patients
by: Gaetano Perchiazzi, et al.
Published: (2022-10-01)

Blood-based cerebral biomarkers in preeclampsia: Plasma concentrations of NfL, tau, S100B and NSE during pregnancy in women who later develop preeclampsia - A nested case control study.
by: Lina Bergman, et al.
Published: (2018-01-01)

486 Quantification of serum neurofilament light chain (NfL) in cubital tunnel
by: Amanda Faust, et al.
Published: (2024-04-01)

Serum NfL in Alzheimer Dementia: Results of the Prospective Dementia Registry Austria
by: Daniela Kern, et al.
Published: (2022-03-01)

In an endotoxaemic model, antibiotic clearance can be affected by different central venous catheter positions, during renal replacement therapy
by: Anna Bandert, et al.
Published: (2023-06-01)

Histone H3 Cleavage in Severe COVID-19 ICU Patients
by: Joram Huckriede, et al.
Published: (2021-09-01)

How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment
by: Bo Nilsson, et al.
Published: (2022-03-01)

Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults
by: Nathan A. Huebschmann, et al.
Published: (2020-09-01)

Clinical-Pathological Study on Expressions β-APP, GFAP, NFL, Spectrin II, CD68 to Verify Diffuse Axonal Injury Diagnosis, Grade and Survival Interval
by: Iuliana Hunea, et al.
Published: (2022-04-01)

Antibiotic use during coronavirus disease 2019 intensive care unit shape multidrug resistance bacteriuria: A Swedish longitudinal prospective study
by: Philip A. Karlsson, et al.
Published: (2023-02-01)

Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients
by: Michael Hultström, et al.
Published: (2022-03-01)

Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation—A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients
by: Michael Hultström, et al.
Published: (2022-06-01)

The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
by: Miklós Lipcsey, et al.
Published: (2021-02-01)

NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study
by: Timo Uphaus, et al.
Published: (2021-10-01)

Correlational Analysis of ALS Progression and Serum NfL Measured by Simoa Assay in Chinese Patients
by: Kazuo Sugimoto, et al.
Published: (2020-12-01)

Dehydration is associated with production of organic osmolytes and predicts physical long-term symptoms after COVID-19: a multicenter cohort study
by: Michael Hultström, et al.
Published: (2022-10-01)